Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Epigenetic Regulation01:37

Epigenetic Regulation

3.5K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

28.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osteolectin/CLEC11A-Related Signaling Molecules in Periodontitis and Peri-Implantitis.

Oral diseases·2026
Same author

NCI's Office of Data Sharing builds momentum to advance cancer research and care.

Journal of the National Cancer Institute·2026
Same author

Synergistic Anticancer Effects of Akkermansia muciniphila Combined With 5-Fluorouracil Through BAX/BCL2 Dependent Apoptosis in Colorectal Cancer Cells.

Cell biochemistry and function·2026
Same author

Neuroprotective and oxidative stress-modulating effects of midazolam, dexmedetomidine and ketamine in a controlled cortical impact model of traumatic brain injury in rats.

Neurological research·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Introduction and Other Protein Targets.

British journal of pharmacology·2025
Same author

Making human derived data FAIR: feedback from NCI office of data sharing workshop.

Journal of the National Cancer Institute·2025

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.

Ercan Cacan1, Mourad W Ali2, Nathaniel H Boyd1

  • 1Division of Cellular Biology and Immunology, Center for Inflammation, Immunity and Infection, Department of Biology, Georgia State University, Atlanta, Georgia, United States of America.

Plos One
|January 30, 2014
PubMed
Summary

Regulator of cell survival RGS10 is silenced in ovarian cancer by epigenetic mechanisms. Inhibiting HDAC1 and DNMT1 restores RGS10, increasing chemoresistance and cell death.

More Related Videos

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

5.6K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.3K

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

5.6K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • RGS10 regulates cell survival and chemoresistance in ovarian cancer.
  • RGS10 transcript expression is suppressed in acquired chemoresistance.
  • Epigenetic silencing via DNA hypermethylation and histone deacetylation contributes to tumor suppressor gene silencing.

Purpose of the Study:

  • To investigate the molecular mechanisms of RGS10 epigenetic silencing in chemoresistant ovarian cancer cells.
  • To identify key epigenetic regulators involved in RGS10 suppression.
  • To evaluate the therapeutic potential of targeting these regulators.

Main Methods:

  • Analysis of RGS10 promoter association with epigenetic regulators (HDAC1, DNMT1) in chemoresistant A2780-AD cells.
  • Gene knockdown of HDAC1 and DNMT1.
  • Pharmacological inhibition of DNMT and HDAC enzymatic activity.
  • Assessment of RGS10 expression and cisplatin-mediated cell death.

Main Results:

  • Aberrant association of HDAC1 and DNMT1 with RGS10 promoters was identified in chemoresistant cells.
  • Knockdown of HDAC1 or DNMT1, or pharmacological inhibition, significantly increased RGS10 expression.
  • RGS10 restoration enhanced cisplatin-mediated ovarian cancer cell death.
  • DNMT1 knockdown reduced HDAC1 binding to the RGS10 promoter, indicating DNMT1 activity is required for HDAC1 recruitment.

Conclusions:

  • HDAC1 and DNMT1 contribute to RGS10 suppression in acquired ovarian cancer chemoresistance.
  • Targeting HDAC1 and DNMT1 may serve as an adjuvant therapy to overcome chemoresistance.
  • Restoring RGS10 expression through epigenetic modulation offers a potential strategy against ovarian cancer.